EPO and anemia (phenotype): Treatment of this disease primarily involves treatment of anemia with transfusions, erythropoietin (EPO) or granulocyte colony stimulating factor (GCSF), and replacement of pancreatic enzymes has been reported in patients with exocrine pancreatic insufficiency [209].